Seattle Genetics | الربح قبل الضريبة



Pre Tax Profit تغيير تاريخ
AbbVie USD 4.81B 1.54B 2024-12
Acadia Pharmaceuticals USD 27.78M 133.31M 2025-03
Agios Pharmaceuticals USD -89289000 16.11M 2025-03
Amgen USD 3.38B 111M 2024-12
Astellas Pharma JPY 60.55B 178.91B 2025-03
Bayer EUR 1.83B 2.31B 2025-03
Biogen USD 572.2M 118.5M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Bristol-Myers Squibb USD 2.97B 1.29B 2025-03
Celldex Therapeutics USD -53796000 6.7M 2025-03
Daiichi Sankyo JPY 80.63B 1.78B 2025-03
Eisai JPY -21000000 29.57B 2025-03
Eli Lilly USD 3.46B 2.08B 2025-03
Exelixis USD 205.69M 20.92M 2025-03
Genmab DKK 244M 3.36B 2025-03
Gilead Sciences USD 2.96B 112M 2024-12
GlaxoSmithKline GBP 2.11B 1.55B 2025-03
Glaxosmithkline USD 1.66B 1.78B 2024-12
Incyte USD 234.19M 172.64M 2025-03
Insmed USD -255671000 21.39M 2025-03
MacroGenics USD -14477000 70.79M 2024-12
Merck USD 5.22B 114M 2024-12
Moderna USD -964000000 220M 2025-03
Novartis USD 4.66B 269M 2024-12
Pfizer USD 4.44B 2.36B 2024-12
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Sanofi EUR 2.16B 20M 2025-03
Sarepta Therapeutics USD -383518000 555.26M 2025-03
Takeda JPY -107299000000 133.71B 2025-03
Teva Pharmaceutical Industries USD 294M 605M 2025-03
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12
Xencor USD -48265000 4.36M 2025-03



Seattle Genetics الربح قبل الضريبة - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Jul 2025.